Oseni

Active Ingredient(s): Alogliptin + Pioglitazone
FDA Approved: * January 25, 2013
Pharm Company: * TAKEDA PHARMS USA
Category: Diabetes

Alogliptin, sold under the brand names Nesina and Vipidia,[1][2]) is an oral anti-diabetic drug in the DPP-4 inhibitor (gliptin) class.[3] Alogliptin does not decrease the risk of heart attack and stroke. Like other members of the gliptin class, it causes little or no weight gain, exhibits relatively little risk of hypoglycemia, and has relatively modest glucose-lowering activity. Alogliptin and other gliptins are commonly used in combination wi... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Oseni 12.5/15 Oral Tablet
NDC: 64764-121
Labeler:
Takeda Pharmaceuticals America, Inc.
Oseni 12.5/30 Oral Tablet
NDC: 64764-123
Labeler:
Takeda Pharmaceuticals America, Inc.
Oseni 12.5/45 Oral Tablet
NDC: 64764-124
Labeler:
Takeda Pharmaceuticals America, Inc.
Oseni 25/15 Oral Tablet
NDC: 64764-251
Labeler:
Takeda Pharmaceuticals America, Inc.
Oseni 25/30 Oral Tablet
NDC: 64764-253
Labeler:
Takeda Pharmaceuticals America, Inc.
Oseni 25/45 Oral Tablet
NDC: 64764-254
Labeler:
Takeda Pharmaceuticals America, Inc.